Although COVID‐19 is primarily a severe respiratory illness, acute myocardial injury is frequently observed, manifested by increased levels of high sensitivity cardiac troponin I (cTnI) or cardiac troponin T (cTnT) in up to 28% of laboratory‐confirmed COVID‐19 patients [84, 85]. The gene discussed is TNNI3; the disease is COVID-19.